We are live on ! Find out more
AVM

Arch Venture Management Portfolio holdings

AUM $677M
1-Year Est. Return 322.07%
This Fund
S&P 500
This Quarter Est. Return
-21.09%
1 Year Est. Return
+322.07%
3 Year Est. Return
+208.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$700M
AUM Growth
-$246M
Cap. Flow
-$1.48M
Cap. Flow %
-0.21%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
MTCR
Metacrine, Inc. Common Stock
MTCR
+$1.54M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$3M
2
PULM icon
Pulmatrix
PULM
+$19K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$369M 52.78%
2,912,872
– –
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
$150M 21.45%
36,335,375
– –
ERAS icon
3
Erasca
ERAS
$6.66B
$95.1M 13.59%
11,055,554
– –
VERV
4
DELISTED
Verve Therapeutics
VERV
$57.3M 8.18%
2,508,809
– –
OMIC
5
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$24M 3.43%
126,631
– –
RUBY
6
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.93M 0.28%
349,908
– –
MTCR
7
DELISTED
Metacrine, Inc. Common Stock
MTCR
$1.79M 0.26%
+2,940,503
New +$1.54M
ZY
8
DELISTED
Zymergen Inc. Common Stock
ZY
$345K 0.05%
119,205
– –
NTRA icon
9
Natera
NTRA
$38.1B
– –
-32,098
Closed -$3M
PULM icon
10
Pulmatrix
PULM
$6.5M
– –
-2,182
Closed -$19K

Similar funds

NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $676M AUM 34.17% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Arch Venture Management's Q1 2022 Portfolio in Review

As of Q1 2022, Arch Venture Management held 10 positions worth $700M, down 26% from $945M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Arch Venture Management's Q1 2022 filing shows 1 new and 2 closed positions. Its largest new stake was Metacrine, Inc. Common Stock: 2,940,503 shares worth $1.79M. The largest sale was Natera, an estimated $3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Arch Venture Management's largest Q1 2022 buy was Metacrine, Inc. Common Stock: 2,940,503 shares worth $1.79M.
  • Arch Venture Management fully exited Natera in Q1 2022, selling an estimated $3M.
  • Arch Venture Management's ten largest holdings make up 100% of its $700M portfolio in Q1 2022.
  • Arch Venture Management opened 1 new position and closed 2 in Q1 2022.
  • Arch Venture Management's portfolio value fell 26% quarter-over-quarter to $700M.

Based on Arch Venture Management's 13F filing for Q1 2022, filed 13 May 2022.